Homayoun Sameyh Najafabadi, a member of the Health Commission of the Parliament, stated that the high cost and lack of insurance coverage for the influenza vaccine have resulted in many people being unable to access the vaccine, leading to the current situation. He added, "The life-threatening risk of influenza has increased compared to COVID-19, meaning the mortality rate of influenza is very high."
Member of the Health Commission: The Mortality Rate of Influenza is Much Higher than that of COVID-19
Homayoun Sameyh Najafabadi highlighted the challenges in accessing the influenza vaccine due to high costs and lack of insurance coverage, leading to increased mortality risks. He emphasized that the danger posed by influenza has surpassed that of COVID-19, raising concerns about public health.
👥 Key Players
📰 What Happened
Homayoun Sameyh Najafabadi raised concerns about the high mortality rate of influenza, stating that it is now greater than that of COVID-19 due to access issues with the influenza vaccine. He highlighted that high costs and lack of insurance coverage are significant barriers for the public.
- Influenza mortality rate is reportedly higher than that of COVID-19.
- Many Iranians cannot access the influenza vaccine due to high costs and lack of insurance.
💡 Why It Matters
📚 Background
Influenza can lead to severe health complications, and access to vaccines is critical for preventing outbreaks. The COVID-19 pandemic has already strained Iran's healthcare system, making vaccine access even more pressing.
🏷️ Entities Mentioned
Translated from the original and edited for English readers. View original source →
Translation confidence: 85%